Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer
Purpose
This phase III trial compares the effect of adding stereotactic body radiation therapy (SBRT) to the usual treatment (conventional image guided radiation therapy [IGRT] and chemotherapy followed by immunotherapy with durvalumab or osimertinib) versus the usual treatment alone in treating patients with non-small cell lung cancer that has spread to nearby tissue or lymph nodes (locally advanced) and cannot be treated by surgery (inoperable). SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. IGRT is a type of radiation that uses a computer to create a picture of the tumor, to help guide the radiation beam during therapy, making it more accurate and causing less damage to healthy tissue. Usual chemotherapy used in this trial consists of combinations of the following drugs: cisplatin, carboplatin, paclitaxel, nab-paclitaxel, pemetrexed, and etoposide. Cisplatin and carboplatin are in a class of medications known as platinum-containing compounds. Cisplatin works by killing, stopping, or slowing the growth of tumor cells. Carboplatin works in a way similar to the anticancer drug cisplatin but may be better tolerated than cisplatin. Carboplatin works by killing, stopping, or slowing the growth of tumor cells as well. Paclitaxel is in a class of medications called antimicrotubule agents. It works by stopping the growth and spread of tumor cells. Nab-paclitaxel is an albumin-stabilized nanoparticle formulation of paclitaxel which may have fewer side effects and work better than other forms of paclitaxel. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by blocking the action of a certain substance in the body that may help tumor cells multiply. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and deoxyribonucleic acid (DNA) repair and may kill tumor cells. Immunotherapy with durvalumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells to grow and spread. Osimertinib is in a class of medications called kinase inhibitors. It works by blocking the action of a protein called EGFR that signals cancer cells to multiply. This helps slow or stop the spread of tumor cells. Adding SBRT to the usual treatment of IGRT with chemotherapy and immunotherapy may be more effective at treating patients with locally-advanced non-small cell lung cancer than giving the usual treatment alone.
Conditions
- Locally Advanced Lung Non-Small Cell Carcinoma
- Stage IIB Lung Cancer AJCC v8
- Stage III Lung Cancer AJCC v8
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Pathologically (histologically or cytologically) proven diagnosis of non-operable stage IIB or III, node positive (American Joint Committee on Cancer [AJCC] eighth edition) non-small cell lung cancer (NSCLC) with known PD-L1 status prior to registration - Patients must have an identified primary tumor and at least one nodal metastasis (peribronchial/hilar/intrapulmonary, mediastinal/subcarinal, supraclavicular/scalene) - Up to 4 cycles of systemic therapy received prior to registration for the current study cancer is allowable; any prior chemotherapy for a different cancer is also permissible - Patients who refuse surgery, in addition to those who are technically unresectable or medically inoperable, are eligible. - Patients with separate tumor nodules in the same lobe of the primary tumor are eligible - The patient must be deemed clinically appropriate for curative intent definitive combined modality therapy, based on the following staging assessments: - History/physical examination prior to registration; - Magnetic resonance imaging (MRI) scan of the brain (preferred) or CT scan of the brain (if available, contrast is preferred for all neuroimaging) prior to registration; - CT chest with IV contrast (if contrast is available and unless contraindicated, such as for abnormal kidney function) prior to registration. PET/CT may be used if the CT portion is of identical diagnostic quality as achieved in a stand-alone CT - No evidence of distant metastases based on FDG PET/CT scan obtained within 60 days of registration - Primary tumor =< 7 cm - Age >= 18 - Eastern Cooperative Oncology Group (ECOG) performance status 0-2 - Hematologic function (e.g. platelets, leukocytes, hemoglobin) amenable, at the discretion of the treating physician, to allow for treatment with chemotherapy and concurrent radiation therapy - Creatinine clearance >= 25 mL/min by the Cockcroft-Gault (C-G) equation - Subjects with non-malignant pleural effusion are eligible provided the effusion is not known or demonstrated to be an exudative effusion - If a pleural effusion is present, the following criteria must be met to exclude malignant involvement: - When pleural fluid is visible on both the CT scan and on a chest x-ray, a pleuracentesis is required to confirm that the pleural fluid is cytologically negative; - Effusions that are minimal (i.e., not visible on chest x-ray) that are too small to safely tap are eligible - Medical history consistent with the patient being amenable, at the discretion of the treating physician, to allow for treating with consolidation immunotherapy. Patients with known EGFR/ALK/other driver mutation at the time of registration are eligible, and these patients can be treated with consolidation systemic therapy at the discretion of the treating physician - Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen - Negative pregnancy test =< 14 days prior to registration for participants of childbearing potential - The patient or a legally authorized representative must provide study-specific informed consent prior to study entry and, for patients treated in the United States (U.S.), authorization permitting release of personal health information
Exclusion Criteria
- Prior radiotherapy to the study cancer (local recurrence). Prior radiotherapy for a different cancer/condition to the region of the study cancer that would result in overlap of radiation therapy fields that is determined by the treating physician to impede the treatment of the study malignancy - Patients without identifiable primary tumor and at least 1 pathologically enlarged lymph node are not eligible (T3-4N0 or T0N1-3 patients are not eligible). At least 1 radiographically-involved lymph node is required, but pathologic confirmation of involvement is not mandated - Centrally located primary tumor < 2 cm from involved nodal disease that would result in significant overlap of the primary SBRT and nodal radiation fields. This does not include proximity to involved segmental and subsegmental lymph nodes (levels 13 and 14) that would not result in overlap of dose to the proximal bronchial tree or esophagus. Centrally located is defined as within or touching the zone of the proximal bronchial tree, which is a volume 2 cm in all directions around the proximal bronchial tree (carina, right and left main bronchi, right and left upper lobe bronchi, intermedius bronchus, right middle lobe bronchus, lingular bronchus right and left lower lobe bronchi) - Participants who are pregnant or unwilling to discontinue nursing - Participants of childbearing potential (participants who may become pregnant or who may impregnate a partner) unwilling to use highly effective contraceptives during therapy and for the Food and Drug Administration (FDA)-labeled contraception timeframe required after the final dose of the selected systemic therapy regimen, because the treatment in this study may be significantly teratogenic
Study Design
- Phase
- Phase 3
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment
- Masking
- None (Open Label)
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Active Comparator Arm I (image guided RT, chemotherapy, immunotherapy) |
Patients undergo conventional IGRT and receive usual care chemotherapy consisting of paclitaxel IV followed by carboplatin IV Q7D during radiotherapy or pemetrexed IV followed by carboplatin IV every 21 days during radiotherapy or etoposide IV on days 1 to 5 and days 29 to 33 followed by cisplatin IV on days 1, 8, 29, and 36 or pemetrexed IV followed by cisplatin IV every 21 days during radiotherapy. Patients then receive consolidation durvalumab IV every 2 or 4 weeks for up to one year in the absence of disease progression or unacceptable toxicity. Patients also undergo CT and/or PET/CT during follow-up. |
|
Experimental Arm II (SBRT, image guided RT, chemotherapy, immunotherapy) |
Patients undergo SBRT and conventional IGRT and receive standard-of-care chemotherapy consisting of paclitaxel IV followed by carboplatin IV Q7D during radiotherapy or pemetrexed IV followed by carboplatin IV every 21 days during radiotherapy or etoposide IV on days 1 to 5 and days 29 to 33 followed by cisplatin IV on days 1, 8, 29, and 36 or pemetrexed IV followed by cisplatin IV every 21 days during radiotherapy. Patients then receive consolidation durvalumab IV every 2 or 4 weeks for up to one year in the absence of disease progression or unacceptable toxicity. Patients also undergo CT and/or PET/CT during follow-up. |
|
Recruiting Locations
Birmingham 4049979, Alabama 4829764 35233
Birmingham 4049979, Alabama 4829764 35243
Kingman 5301067, Arizona 5551752 86401
Phoenix 5308655, Arizona 5551752 85004
Tucson 5318313, Arizona 5551752 85719
Tucson 5318313, Arizona 5551752 85719
Jonesboro 4116834, Arkansas 4099753 72401
Little Rock 4119403, Arkansas 4099753 72205
Site Public Contact
501-686-8274
Bakersfield 5325738, California 5332921 93301
Site Public Contact
661-323-4673
Burlingame 5331920, California 5332921 94010
Fremont 5350734, California 5332921 94538
Los Angeles 5368361, California 5332921 90033
Los Angeles 5368361, California 5332921 90033
Site Public Contact
323-865-0451
Marysville 5370984, California 5332921 95901
Site Public Contact
530-749-4400
Modesto 5373900, California 5332921 95355
Mountain View 5375480, California 5332921 94040
Palo Alto 5380748, California 5332921 94301
Roseville 5388881, California 5332921 95661
Roseville 5388881, California 5332921 95661
Sacramento 5389489, California 5332921 95816
San Francisco 5391959, California 5332921 94115
San Mateo 5392423, California 5332921 94401
Santa Rosa 5393287, California 5332921 95403
Sunnyvale 5400075, California 5332921 94086
Vallejo 5405380, California 5332921 94589
Aurora 5412347, Colorado 5417618 80045
Site Public Contact
720-848-0650
Colorado Springs 5417598, Colorado 5417618 80907
Colorado Springs 5417598, Colorado 5417618 80909
Site Public Contact
719-365-2406
Colorado Springs 5417598, Colorado 5417618 80920
Site Public Contact
719-364-6700
Denver 5419384, Colorado 5417618 80206
Fort Collins 5577147, Colorado 5417618 80524
Site Public Contact
970-297-6150
Fort Collins 5577147, Colorado 5417618 80528
Greeley 5577592, Colorado 5417618 80631
Highlands Ranch 5425043, Colorado 5417618 80129
Site Public Contact
720-848-0650
Lone Tree 5429208, Colorado 5417618 80124
Loveland 5579368, Colorado 5417618 80538
Site Public Contact
970-203-7083
Lewes 4143354, Delaware 4142224 19958
Millville 4143696, Delaware 4142224 19967
Newark 4143861, Delaware 4142224 19713
Newark 4143861, Delaware 4142224 19713
Newark 4143861, Delaware 4142224 19718
Rehoboth Beach 4144284, Delaware 4142224 19971
Wilmington 4145381, Delaware 4142224 19801
Clearwater 4151316, Florida 4155751 33756
Site Public Contact
855-314-8646
Daytona Beach 4152872, Florida 4155751 32114
Site Public Contact
386-254-4211
Jacksonville 4160021, Florida 4155751 32224-9980
Site Public Contact
855-776-0015
Jupiter 4160610, Florida 4155751 33458
Site Public Contact
561-745-5768
Orlando 4167147, Florida 4155751 32806
Tampa 4174757, Florida 4155751 33607
Winter Haven 4178552, Florida 4155751 33881
Atlanta 4180439, Georgia 4197000 30303
Site Public Contact
404-778-1868
Atlanta 4180439, Georgia 4197000 30308
Atlanta 4180439, Georgia 4197000 30308
Site Public Contact
888-946-7447
Atlanta 4180439, Georgia 4197000 30322
Site Public Contact
404-778-1868
Atlanta 4180439, Georgia 4197000 30342
Site Public Contact
404-851-7115
Augusta 4180531, Georgia 4197000 30912
Austell 4180564, Georgia 4197000 30106
Dalton 4190581, Georgia 4197000 30720
Marietta 4207783, Georgia 4197000 30060
Newnan 4212684, Georgia 4197000 30265
Site Public Contact
770-400-6629
Honolulu 5856195, Hawaii 5855797 96813
Honolulu 5856195, Hawaii 5855797 96813
Site Public Contact
808-532-0315
Honolulu 5856195, Hawaii 5855797 96813
Site Public Contact
808-545-8548
Honolulu 5856195, Hawaii 5855797 96813
Site Public Contact
808-522-4333
Honolulu 5856195, Hawaii 5855797 96813
Site Public Contact
808-586-2979
Honolulu 5856195, Hawaii 5855797 96817
Site Public Contact
808-547-9816
Honolulu 5856195, Hawaii 5855797 96817
Site Public Contact
808-531-8521
Honolulu 5856195, Hawaii 5855797 96817
Site Public Contact
808-547-6881
‘Aiea 5856430, Hawaii 5855797 96701
‘Aiea 5856430, Hawaii 5855797 96701
Site Public Contact
808-486-6000
Aurora 4883817, Illinois 4896861 60504
Aurora 4883817, Illinois 4896861 60506
Barrington 4884116, Illinois 4896861 60010
Site Public Contact
847-842-4847
Bloomington 4885164, Illinois 4896861 61701
Bloomington 4885164, Illinois 4896861 61704
Canton 4831990, Illinois 4896861 61520
Carthage 4886716, Illinois 4896861 62321
Centralia 4235587, Illinois 4896861 62801
Chicago 4887398, Illinois 4896861 60611
Chicago 4887398, Illinois 4896861 60657
Site Public Contact
773-296-5360
Crystal Lake 4889229, Illinois 4896861 60014
Danville 4889426, Illinois 4896861 61832
Decatur 4236895, Illinois 4896861 62526
Decatur 4236895, Illinois 4896861 62526
DeKalb 4889553, Illinois 4896861 60115
Downers Grove 4890119, Illinois 4896861 60515
Effingham 4237727, Illinois 4896861 62401
Effingham 4237727, Illinois 4896861 62401
Elgin 4890864, Illinois 4896861 60123
Site Public Contact
847-429-2907
Eureka 4891310, Illinois 4896861 61530
Galesburg 4893392, Illinois 4896861 61401
Geneva 4893591, Illinois 4896861 60134
Hazel Crest 4895416, Illinois 4896861 60429
Site Public Contact
708-799-9995
Kewanee 4898433, Illinois 4896861 61443
Libertyville 4899739, Illinois 4896861 60048
Libertyville 4899739, Illinois 4896861 60048
Macomb 4900817, Illinois 4896861 61455
Mattoon 4244099, Illinois 4896861 61938
O'Fallon 4245926, Illinois 4896861 62269
O'Fallon 4245926, Illinois 4896861 62269
Oak Lawn 4904365, Illinois 4896861 60453-2699
Site Public Contact
800-323-8622
Ottawa 4905006, Illinois 4896861 61350
Palos Heights 4905259, Illinois 4896861 60463
Park Ridge 4905367, Illinois 4896861 60068
Site Public Contact
847-384-3621
Pekin 4905599, Illinois 4896861 61554
Peoria 4905687, Illinois 4896861 61615
Peoria 4905687, Illinois 4896861 61615
Peoria 4905687, Illinois 4896861 61636
Peoria 4905687, Illinois 4896861 61637
Peru 4905770, Illinois 4896861 61354
Princeton 4906818, Illinois 4896861 61356
Rockford 4907959, Illinois 4896861 61114
Springfield 4250542, Illinois 4896861 62702
Site Public Contact
217-545-7929
Springfield 4250542, Illinois 4896861 62702
Site Public Contact
800-444-7541
Springfield 4250542, Illinois 4896861 62781
Urbana 4914570, Illinois 4896861 61801
Warrenville 4915525, Illinois 4896861 60555
Washington 4915545, Illinois 4896861 61571
Zion 4917358, Illinois 4896861 60099
Site Public Contact
844-793-0745
Crown Point 4919451, Indiana 4921868 46307
Site Public Contact
219-310-2550
Dyer 4919820, Indiana 4921868 46311
Site Public Contact
219-924-8178
Hobart 4921476, Indiana 4921868 46342
Site Public Contact
219-947-1795
Hobart 4921476, Indiana 4921868 46342
Munster 4924014, Indiana 4921868 46321
Site Public Contact
219-836-3349
Munster 4924014, Indiana 4921868 46321
Valparaiso 4927537, Indiana 4921868 46383
Ames 4846834, Iowa 4862182 50010
Site Public Contact
515-956-4132
Ames 4846834, Iowa 4862182 50010
Ankeny 4846960, Iowa 4862182 50023
Site Public Contact
515-241-3305
Cedar Rapids 4850751, Iowa 4862182 52402
Clive 4852065, Iowa 4862182 50325
Site Public Contact
515-241-3305
Council Bluffs 4852832, Iowa 4862182 51503
Site Public Contact
712-322-4136
Council Bluffs 4852832, Iowa 4862182 51503
Des Moines 4853828, Iowa 4862182 50309
Site Public Contact
515-241-6727
Des Moines 4853828, Iowa 4862182 50309
Site Public Contact
515-241-3305
Des Moines 4853828, Iowa 4862182 50314
Site Public Contact
515-241-3305
Waukee 4880981, Iowa 4862182 50263
Site Public Contact
515-241-3305
Kansas City 4273837, Kansas 4273857 66160
Olathe 4276614, Kansas 4273857 66061
Overland Park 4276873, Kansas 4273857 66210
Salina 4278890, Kansas 4273857 67401
Topeka 4280539, Kansas 4273857 66606
Site Public Contact
785-295-8000
Westwood 4281639, Kansas 4273857 66205
Wichita 4281730, Kansas 4273857 67214
Lexington 4297983, Kentucky 6254925 40536
Site Public Contact
859-257-3379
New Orleans 4335045, Louisiana 4331987 70112
New Orleans 4335045, Louisiana 4331987 70112
Portland 4975802, Maine 4971068 04102
Sanford 4977762, Maine 4971068 04073
Site Public Contact
207-459-1600
Scarborough 4977882, Maine 4971068 04074
South Portland 4979244, Maine 4971068 04106
Baltimore 4347778, Maryland 4361885 21204
Site Public Contact
443-849-3706
Baltimore 4347778, Maryland 4361885 21215
Site Public Contact
410-601-9083
Ocean Pines 4364326, Maryland 4361885 21811
Salisbury 4368711, Maryland 4361885 21801
Westminster 4373238, Maryland 4361885 21157
Site Public Contact
410-871-6400
Worcester 4956184, Massachusetts 6254926 01655
Ann Arbor 4984247, Michigan 5001836 48106
Bay City 4985180, Michigan 5001836 48706
Brighton 4986994, Michigan 5001836 48114
Brighton 4986994, Michigan 5001836 48114
Chelsea 4988628, Michigan 5001836 48118
Chelsea 4988628, Michigan 5001836 48118
Clarkston 4988997, Michigan 5001836 48346
Clarkston 4988997, Michigan 5001836 48346
Detroit 4990729, Michigan 5001836 48201
Farmington Hills 4992523, Michigan 5001836 48334
Farmington Hills 4992523, Michigan 5001836 48334
Farmington Hills 4992523, Michigan 5001836 48336
Site Public Contact
248-551-7695
Flint 4992982, Michigan 5001836 48532
Grand Rapids 4994358, Michigan 5001836 49503
Kalamazoo 4997787, Michigan 5001836 49007
Kalamazoo 4997787, Michigan 5001836 49007
Kalamazoo 4997787, Michigan 5001836 49048
Site Public Contact
574-647-7370
Lansing 4998830, Michigan 5001836 48910
Lansing 4998830, Michigan 5001836 48912
Lapeer 4998842, Michigan 5001836 48446
Livonia 4999837, Michigan 5001836 48154
Macomb 5000473, Michigan 5001836 48044
Madison Heights 5000500, Michigan 5001836 48071
Mount Clemens 5002656, Michigan 5001836 48043
Petoskey 5005484, Michigan 5001836 49770
Pontiac 5006166, Michigan 5001836 48341
Pontiac 5006166, Michigan 5001836 48341
Port Huron 5006233, Michigan 5001836 48060
Royal Oak 5007804, Michigan 5001836 48073
Site Public Contact
248-551-7695
Traverse City 5012495, Michigan 5001836 49684
Troy 5012639, Michigan 5001836 48085
Site Public Contact
248-551-7695
Troy 5012639, Michigan 5001836 48098
Warren 5014051, Michigan 5001836 48093
Wyoming 5015618, Michigan 5001836 49519
Ypsilanti 5015688, Michigan 5001836 48197
Bemidji 5017822, Minnesota 5037779 56601
Brainerd 5019116, Minnesota 5037779 56401
Deer River 5024099, Minnesota 5037779 56636
Duluth 5024719, Minnesota 5037779 55805
Duluth 5024719, Minnesota 5037779 55805
Duluth 5024719, Minnesota 5037779 55805
Hibbing 5030005, Minnesota 5037779 55746
Site Public Contact
218-786-3308
Rochester 5043473, Minnesota 5037779 55905
Site Public Contact
855-776-0015
Saint Cloud 5044407, Minnesota 5037779 56303
Sandstone 5045908, Minnesota 5037779 55072
Virginia 5051468, Minnesota 5037779 55792
Southhaven 4446702, Mississippi 4436296 38671
Cape Girardeau 4379966, Missouri 4398678 63703
Farmington 4386289, Missouri 4398678 63640
Site Public Contact
314-996-5569
Joplin 4392768, Missouri 4398678 64804
Kansas City 4393217, Missouri 4398678 64154
Lee's Summit 4394870, Missouri 4398678 64064
Sainte Genevieve 4407294, Missouri 4398678 63670
Site Public Contact
314-996-5569
Springfield 4409896, Missouri 4398678 65804
Site Public Contact
417-269-4520
St Louis 4407066, Missouri 4398678 63128
St Louis 4407066, Missouri 4398678 63131
Site Public Contact
314-996-5569
St Louis 4407066, Missouri 4398678 63141
Site Public Contact
314-251-7066
Sullivan 4410669, Missouri 4398678 63080
Site Public Contact
314-996-5569
Sunset Hills 4410836, Missouri 4398678 63127
Site Public Contact
314-996-5569
Billings 5640350, Montana 5667009 59101
Bozeman 5641727, Montana 5667009 59715
Great Falls 5655240, Montana 5667009 59405
Omaha 5074472, Nebraska 5073708 68114
Site Public Contact
402-334-4773
Omaha 5074472, Nebraska 5073708 68114
Site Public Contact
402-354-5144
Reno 5511077, Nevada 5509151 89502
Lebanon 5088597, New Hampshire 5090174 03756
Basking Ridge 5095409, New Jersey 5101760 07920
Site Public Contact
212-639-7592
Camden 4501018, New Jersey 5101760 08103
Site Public Contact
856-325-6757
Hamilton 5098765, New Jersey 5101760 08690
Site Public Contact
609-631-6946
Jersey City 5099836, New Jersey 5101760 07302
Lakewood 5100280, New Jersey 5101760 08701
Livingston 5100572, New Jersey 5101760 07039
Long Branch 5100619, New Jersey 5101760 07740
Middletown 5101170, New Jersey 5101760 07748
Site Public Contact
212-639-7592
Montvale 5101361, New Jersey 5101760 07645
Site Public Contact
212-639-7592
New Brunswick 5101717, New Jersey 5101760 08903
Site Public Contact
732-235-7356
Newark 5101798, New Jersey 5101760 07101
Site Public Contact
732-235-7356
Sewell 4504048, New Jersey 5101760 08080
Somerville 5104774, New Jersey 5101760 08876
Toms River 4504476, New Jersey 5101760 08755
Albuquerque 5454711, New Mexico 5481136 87106
Albuquerque 5454711, New Mexico 5481136 87110
Las Cruces 5475352, New Mexico 5481136 88011
Rio Rancho 5487811, New Mexico 5481136 87124
Batavia 5108093, New York 5128638 14020
Canandaigua 5111405, New York 5128638 14424
Site Public Contact
585-396-6161
Commack 5113412, New York 5128638 11725
Site Public Contact
212-639-7592
Glens Falls 5118693, New York 5128638 12801
Site Public Contact
518-926-6700
Harrison 5120095, New York 5128638 10604
Site Public Contact
212-639-7592
New York 5128581, New York 5128638 10035
New York 5128581, New York 5128638 10065
Site Public Contact
212-639-7592
Rochester 5134086, New York 5128638 14606
Site Public Contact
585-758-7877
Rochester 5134086, New York 5128638 14620
Site Public Contact
585-341-8113
Rochester 5134086, New York 5128638 14642
Site Public Contact
585-275-5830
Stony Brook 5139865, New York 5128638 11794
Site Public Contact
800-862-2215
Syracuse 5140405, New York 5128638 13210
Site Public Contact
315-464-5476
The Bronx 5110266, New York 5128638 10461
The Bronx 5110266, New York 5128638 10461
The Bronx 5110266, New York 5128638 10467
Uniondale 5141927, New York 5128638 11553
Site Public Contact
212-639-7592
Valhalla 5142090, New York 5128638 10595
Webster 5143495, New York 5128638 14580
Albemarle 4452303, North Carolina 4482348 28002
Site Public Contact
800-804-9376
Cary 4459467, North Carolina 4482348 27518
Chapel Hill 4460162, North Carolina 4482348 27599
Charlotte 4460243, North Carolina 4482348 28203
Site Public Contact
800-804-9376
Charlotte 4460243, North Carolina 4482348 28204
Charlotte 4460243, North Carolina 4482348 28210
Site Public Contact
980-442-2000
Charlotte 4460243, North Carolina 4482348 28262
Site Public Contact
800-804-9376
Clemmons 4461015, North Carolina 4482348 27012
Site Public Contact
888-716-9259
Concord 4461574, North Carolina 4482348 28025
Site Public Contact
800-804-9376
Durham 4464368, North Carolina 4482348 27710
Site Public Contact
888-275-3853
Forest City 4466720, North Carolina 4482348 28043
Site Public Contact
800-804-9376
Gastonia 4467732, North Carolina 4482348 28054
Greensboro 4469146, North Carolina 4482348 27403
Huntersville 4472370, North Carolina 4482348 28078
Huntersville 4472370, North Carolina 4482348 28078
Kernersville 4474221, North Carolina 4482348 27284
Matthews 4478334, North Carolina 4482348 28104
Site Public Contact
980-442-0600
Matthews 4478334, North Carolina 4482348 28105
Matthews 4478334, North Carolina 4482348 28105
Monroe 4479946, North Carolina 4482348 28112
Site Public Contact
980-442-2000
Mooresville 4480125, North Carolina 4482348 28117
Mount Airy 4480378, North Carolina 4482348 27030
North Wilkesboro 4482577, North Carolina 4482348 28659
Raleigh 4487042, North Carolina 4482348 27609
Salisbury 4489985, North Carolina 4482348 28144
Salisbury 4489985, North Carolina 4482348 28144
Shelby 4491180, North Carolina 4482348 28150
Site Public Contact
800-804-9376
Statesville 4493316, North Carolina 4482348 28625
Statesville 4493316, North Carolina 4482348 28677
Site Public Contact
704-872-3630
Supply 4830472, North Carolina 4482348 28462
Site Public Contact
910-754-4716
Thomasville 4494942, North Carolina 4482348 27360
Wilkesboro 4499138, North Carolina 4482348 28659
Site Public Contact
888-716-9253
Wilmington 4499379, North Carolina 4482348 28401
Site Public Contact
910-251-1839
Wilmington 4499379, North Carolina 4482348 28401
Site Public Contact
910-342-3000
Winston-Salem 4499612, North Carolina 4482348 27103
Winston-Salem 4499612, North Carolina 4482348 27157
Site Public Contact
336-713-6771
Bismarck 5688025, North Dakota 5690763 58501
Fargo 5059163, North Dakota 5690763 58122
Fargo 5059163, North Dakota 5690763 58122
Grand Forks 5059429, North Dakota 5690763 58201
Site Public Contact
701-780-6520
Akron 5145476, Ohio 5165418 44307
Avon 5146277, Ohio 5165418 44011
Site Public Contact
800-641-2422
Beachwood 5146711, Ohio 5165418 44122
Canton 5149222, Ohio 5165418 44708
Site Public Contact
888-293-4673
Canton 5149222, Ohio 5165418 44710
Centerville 4508204, Ohio 5165418 45459
Cleveland 5150529, Ohio 5165418 44106
Columbus 4509177, Ohio 5165418 43214
Columbus 4509177, Ohio 5165418 43215
Columbus 4509177, Ohio 5165418 43228
Dayton 4509884, Ohio 5165418 45409
Dayton 4509884, Ohio 5165418 45409
Site Public Contact
937-276-8320
Dayton 4509884, Ohio 5165418 45415
Delaware 5151891, Ohio 5165418 43015
Delaware 5151891, Ohio 5165418 43015
Dublin 5152333, Ohio 5165418 43016
Franklin 4512203, Ohio 5165418 45005-1066
Greenville 5156493, Ohio 5165418 45331
Site Public Contact
937-569-7515
Mansfield 5161723, Ohio 5165418 44903
Marion 5161902, Ohio 5165418 43302
Mentor 5162645, Ohio 5165418 44060
Perrysburg 5166516, Ohio 5165418 43551
Troy 5174358, Ohio 5165418 45373
Oklahoma City 4544349, Oklahoma 4544379 73104
Gresham 5729485, Oregon 5744337 97030
Site Public Contact
503-413-2150
Portland 5746545, Oregon 5744337 97210
Tualatin 5757506, Oregon 5744337 97062
Site Public Contact
503-413-1742
Chadds Ford 4557084, Pennsylvania 6254927 19317
Chambersburg 4557109, Pennsylvania 6254927 17201
Danville 5186327, Pennsylvania 6254927 17822
Ephrata 5188815, Pennsylvania 6254927 17522
Site Public Contact
717-721-4840
Gettysburg 4558183, Pennsylvania 6254927 17325
Site Public Contact
877-441-7957
Hershey 5193342, Pennsylvania 6254927 17033-0850
Lancaster 5197079, Pennsylvania 6254927 17601
Lebanon 5197517, Pennsylvania 6254927 17042
Lewisburg 5197842, Pennsylvania 6254927 17837
Philadelphia 4560349, Pennsylvania 6254927 19104
Philadelphia 4560349, Pennsylvania 6254927 19107
Philadelphia 4560349, Pennsylvania 6254927 19111
Site Public Contact
215-728-4790
Philadelphia 4560349, Pennsylvania 6254927 19140
Site Public Contact
215-728-2983
West Reading 5218867, Pennsylvania 6254927 19611
Site Public Contact
610-988-9323
Wilkes-Barre 5219488, Pennsylvania 6254927 18711
Willow Grove 5219619, Pennsylvania 6254927 19090
Wynnewood 5220230, Pennsylvania 6254927 19096
York 4562407, Pennsylvania 6254927 17403
Site Public Contact
877-441-7957
York 4562407, Pennsylvania 6254927 17403
Site Public Contact
877-441-7957
Gaffney 4579418, South Carolina 4597040 29341
Greer 4580599, South Carolina 4597040 29651
Lancaster 4584556, South Carolina 4597040 29720
Site Public Contact
800-804-9376
Rock Hill 4593142, South Carolina 4597040 29730
Site Public Contact
800-804-9376
Rock Hill 4593142, South Carolina 4597040 29732
Site Public Contact
800-804-9376
Spartanburg 4597200, South Carolina 4597040 29303
Union 4599214, South Carolina 4597040 29379
West Columbia 4600541, South Carolina 4597040 29169
Sioux Falls 5231851, South Dakota 5769223 57104
Sioux Falls 5231851, South Dakota 5769223 57117-5134
Collierville 4614748, Tennessee 4662168 38017
Memphis 4641239, Tennessee 4662168 38120
Conroe 4682991, Texas 4736286 77384
Houston 4699066, Texas 4736286 77030
Houston 4699066, Texas 4736286 77079
League City 4705692, Texas 4736286 77573
Sugar Land 4734825, Texas 4736286 77478
Berlin Corners 5233780, Vermont 5242283 05602
Site Public Contact
802-225-5400
Burlington 5234372, Vermont 5242283 05401
Burlington 5234372, Vermont 5242283 05405
Saint Johnsbury 5240656, Vermont 5242283 05819
Vancouver 5814616, Washington 5815135 98684
Vancouver 5814616, Washington 5815135 98686
Site Public Contact
503-413-2150
Huntington 4809537, West Virginia 4826850 25701
Morgantown 4815352, West Virginia 4826850 26506
Antigo 5244010, Wisconsin 5279468 54409
Ashland 5244247, Wisconsin 5279468 54806
Ashland 5244247, Wisconsin 5279468 54806
Burlington 5247214, Wisconsin 5279468 53105
Eau Claire 5251436, Wisconsin 5279468 54701
Germantown 5254218, Wisconsin 5279468 53022
Grafton 5254739, Wisconsin 5279468 53024
Green Bay 5254962, Wisconsin 5279468 54301
Green Bay 5254962, Wisconsin 5279468 54311
Hayward 5255882, Wisconsin 5279468 54843
Johnson Creek 5257996, Wisconsin 5279468 53038
Kenosha 5258393, Wisconsin 5279468 53142
Madison 5261457, Wisconsin 5279468 53705
Site Public Contact
608-256-1901
Madison 5261457, Wisconsin 5279468 53718
Madison 5261457, Wisconsin 5279468 53792
Marinette 5261852, Wisconsin 5279468 54143
Marshfield 5261969, Wisconsin 5279468 54449
Menomonee Falls 5262630, Wisconsin 5279468 53051
Site Public Contact
262-257-5100
Milwaukee 5263045, Wisconsin 5279468 53209
Milwaukee 5263045, Wisconsin 5279468 53215
Milwaukee 5263045, Wisconsin 5279468 53226
Site Public Contact
414-805-3666
Milwaukee 5263045, Wisconsin 5279468 53233
Milwaukee 5263045, Wisconsin 5279468 53295
Site Public Contact
888-469-6614
Minocqua 5263156, Wisconsin 5279468 54548
Mukwonago 5263965, Wisconsin 5279468 53149
Oak Creek 5265228, Wisconsin 5279468 53154
Site Public Contact
414-805-0505
Oconomowoc 5265499, Wisconsin 5279468 53066
Site Public Contact
262-928-7878
Oshkosh 5265838, Wisconsin 5279468 54904
Racine 5268249, Wisconsin 5279468 53406
Rhinelander 5268720, Wisconsin 5279468 54501
Rice Lake 5268798, Wisconsin 5279468 54868
Sheboygan 5272893, Wisconsin 5279468 53081
Sheboygan 5272893, Wisconsin 5279468 53081
Spooner 5274034, Wisconsin 5279468 54801
Stevens Point 5274644, Wisconsin 5279468 54481
Stevens Point 5274644, Wisconsin 5279468 54482
Sturgeon Bay 5274867, Wisconsin 5279468 54235-1495
Summit, Wisconsin 5279468 53066
Superior 5275191, Wisconsin 5279468 54880
Site Public Contact
701-364-6272
Waukesha 5278052, Wisconsin 5279468 53188
Wausau 5278120, Wisconsin 5279468 54401
Site Public Contact
877-405-6866
Wauwatosa 5278159, Wisconsin 5279468 53226
West Allis 5278420, Wisconsin 5279468 53227
West Bend 5278422, Wisconsin 5279468 53095
Site Public Contact
414-805-0505
Weston 5278693, Wisconsin 5279468 54476
Wisconsin Rapids 5279436, Wisconsin 5279468 54494
Site Public Contact
715-422-7718
More Details
- NCT ID
- NCT05624996
- Status
- Recruiting
- Sponsor
- NRG Oncology
Detailed Description
PRIMARY OBJECTIVES: I. To compare the overall survival in patients with stage II-IIIC inoperable node-positive non-small cell lung cancer (NSCLC) after image guided, motion-managed conventional radiotherapy to the primary tumor and nodal metastases (Arm 1) or after image guided, motion-managed stereotactic body radiation therapy (SBRT) to the primary tumor followed by conventionally fractionated radiotherapy to nodal metastases (Arm 2) both given with concurrent platinum-based chemotherapy. II. To compare progression-free survival between the experimental arm (Arm 2) and control arm (Arm 1). SECONDARY OBJECTIVES: I. To compare objective response rate (as defined by Response Evaluation Criteria in Solid Tumors [RECIST] version [v] 1.1) between the experimental arm and control arm. II. To compare the rate of local control between the experimental arm and control arm. III. To compare patterns of failure (primary, locoregional, or distant) between the experimental arm and control arm. IV. To compare changes in pulmonary function (forced expiratory volume in 1 second [FEV1] and diffusion capacity of the lung for carbon monoxide [DLCO] assessed at randomization and at 6- and 12- months following completion of radiation therapy) between the experimental arm and control arm. V. To compare changes in quality of life and patient-reported outcomes assessed from pre-treatment to 3 months following radiation therapy of each treatment arm. VI. To determine acute and late toxicity profiles of each treatment arm as measured by the Common Terminology Criteria for Adverse Events (CTCAE) v5. EXPLORATORY OBJECTIVES: I. To characterize and compare longitudinal quality of life and patient-reported outcomes of each treatment arm. II. To collect biospecimens at baseline, after SBRT (for Arm 2 patients), during last 2 weeks of chemoradiation, and after first dose of consolidation therapy, to allow for future analyses. III. To collect 4-dimensional (4D) computed tomography (CT) planning scans and radiation dose to calculate regional lung ventilation and explore pre-treatment 4D-CT based ventilation to predict pulmonary toxicity. IV. To characterize clinical outcomes, toxicities and changes in pulmonary function and quality of life among patients receiving proton and photon radiotherapy. V. To develop and characterize a machine learning/artificial intelligence algorithm for radiotherapy planning and/or quality assurance. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I: Patients undergo conventional IGRT and receive usual care chemotherapy consisting of paclitaxel intravenously (IV) followed by carboplatin IV weekly (Q7D) during radiotherapy or pemetrexed IV followed by carboplatin IV every 21 days during radiotherapy or etoposide IV on days 1 to 5 and days 29 to 33 followed by cisplatin IV on days 1, 8, 29, and 36 or pemetrexed IV followed by cisplatin IV every 21 days during radiotherapy. Patients then receive consolidation durvalumab IV every 2 or 4 weeks for up to one year in the absence of disease progression or unacceptable toxicity. Patients also undergo CT and/or positron emission tomography (PET)/CT during follow-up. ARM II: Patients undergo SBRT and conventional IGRT and receive standard-of-care chemotherapy consisting of paclitaxel IV followed by carboplatin IV Q7D during radiotherapy or pemetrexed IV followed by carboplatin IV every 21 days during radiotherapy or etoposide IV on days 1 to 5 and days 29 to 33 followed by cisplatin IV on days 1, 8, 29, and 36 or pemetrexed IV followed by cisplatin IV every 21 days during radiotherapy. Patients then receive consolidation durvalumab IV every 2 or 4 weeks for up to one year in the absence of disease progression or unacceptable toxicity. Patients also undergo CT and/or PET/CT during follow-up. Patients are followed up every 3 months for 1 year, every 6 months during years 2 and 3, and then yearly after that for the duration of the study.